IINN icon

Inspira Technologies Oxy

0.8901 USD
-0.0427
4.58%
At close Dec 20, 4:00 PM EST
After hours
0.9000
+0.0099
1.11%
1 day
-4.58%
5 days
-23.27%
1 month
-32.57%
3 months
-27.04%
6 months
-36.42%
Year to date
-12.74%
1 year
-19.81%
5 years
-81.26%
10 years
-81.26%
 

About: Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Employees: 42

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

11% more funds holding

Funds holding: 9 [Q2] → 10 (+1) [Q3]

0.33% less ownership

Funds ownership: 1.08% [Q2] → 0.75% (-0.33%) [Q3]

31% less capital invested

Capital invested by funds: $274K [Q2] → $188K (-$85.9K) [Q3]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Research analyst outlook

We haven’t received any recent analyst ratings for IINN.

Financial journalist opinion

Based on 3 articles about IINN published over the past 30 days

Neutral
PRNewsWire
5 days ago
Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment
RA'ANANA, Israel , Dec. 16, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN, IINNW), ("Inspira Technologies," "Inspira" or the "Company"), a groundbreaking respiratory support technology company, announced the delivery of INSPIRA™ ART100 systems to its U.S. distributor, Glo-Med Networks Inc ("Glo-Med").
Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment
Neutral
PRNewsWire
1 week ago
Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions
RA'ANANA, Israel , Dec. 10, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN, IINNW), ("Inspira Technologies" or the "Company"), a groundbreaking life support technology company, revealed the expansion of its HYLA blood sensor technology ("HYLA") into an immediate personalized Blood Lab Test, aimed at performing real-time patient blood work for the rapid detection in minutes of the potential development of an underlying life-threatening medical condition.
Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions
Neutral
PRNewsWire
2 weeks ago
Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios
RA'ANANA, Israel , Dec. 4, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN), (Nasdaq: IINNW) ("Inspira Technologies", "Inspira" or the "Company"), a groundbreaking life support technology company, entered into a strategic collaboration with Westchester Medical Center in Valhalla, New York.
Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios
Neutral
PRNewsWire
1 month ago
Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11
RA'ANANA, Israel, Nov. 8, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN), ("Inspira Technologies" or the "Company"), an innovative medical technology company in the life support and respiratory treatment arena, is pleased to invite investors to a webinar on November 11, 2024, at 4:15 p.m.
Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11
Neutral
PRNewsWire
1 month ago
Inspira™ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA™ ART100
The Company has signed a distribution agreement that assigns to Glo-Med the role of Inspira's primary distributor and customer support center in the U.S. RA'ANANA, Israel , Oct. 24, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira Technologies", "Inspira" or the "Company"), a groundbreaking life support technology company, is pleased to announce that it has entered into an agreement with Glo-Med Networks Inc ("Glo-Med"), which will serve as Inspira's primary distributor in the United States.
Inspira™ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA™ ART100
Neutral
PRNewsWire
2 months ago
Inspira™ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
RA'ANANA, Israel , Oct. 9, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) ("Inspira Technologies", "Inspira" or the "Company"), a groundbreaking respiratory support technology company, is pleased to announce the development of a new disposable kit for the perfusion market.
Inspira™ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
Positive
Zacks Investment Research
2 months ago
Inspira Stock to Gain From its Appearance at Annual ELSO Conference
At the 34th annual ELSO conference in Detroit, IINN will present its FDA-cleared latest and future technology, the INSPIRA ART100 system.
Inspira Stock to Gain From its Appearance at Annual ELSO Conference
Neutral
PRNewsWire
2 months ago
Inspira™ Launches INSPIRA™ ART100 at the World's Largest Extracorporeal Life Support Conference
RA'ANANA, Israel , Sept. 24, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N.
Inspira™ Launches INSPIRA™ ART100 at the World's Largest Extracorporeal Life Support Conference
Positive
Zacks Investment Research
3 months ago
IINN Stock Gains on Second US Patent Approval for VORTX System
Inspira secures a second U.S. Patent approval for the VORTX orbiting blood oxygenation delivery system.
IINN Stock Gains on Second US Patent Approval for VORTX System
Neutral
PRNewsWire
3 months ago
Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System
To date, a combined total of 32 claims have been deemed novel for the core technology of the INSPIRA™ ART device Targeting treatment for 20 million ICU patients with respiratory failure annually, with many relying on mechanical ventilators, in a $19 billion industry RA'ANANA, Israel , Sept. 13, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N.
Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System
Charts implemented using Lightweight Charts™